Oura, the company renowned for its innovative smart rings that monitor health metrics, has decided to halt its plans to go public in the United States. This move came shortly after the company revealed ambitions to value itself at approximately $15 billion (£11.3 billion). In a statement, Oura cited “uncertainty in the Initial Public Offering (IPO) market” as the primary reason for postponing its flotation, without specifying when it might revisit the decision.
Just over a week ago, Oura had submitted official documentation indicating intentions to raise up to $2.2 billion by offering shares to investors. The tech sector is increasingly seeing companies delay their public listings, with industry analysts suggesting that conditions for IPOs are becoming more challenging.
Tom Hale, CEO of Oura, commented that “an IPO is just one step in our journey,” emphasizing that they have “the luxury of choosing our moment.” This reflects a broader trend, as other firms, including Holtec International, have also opted to postpone their public offerings due to various economic factors affecting investor confidence.
Holtec’s delay was attributed to “an unusual confluence of developments,” including rising energy costs, military conflicts, international trade tensions, and inflation concerns. These issues have prompted central banks, including the U.S. Federal Reserve, to increase benchmark interest rates.
This week, the yield on U.S. debt with a ten-year repayment period reached its highest point since 2007, highlighting the evolving landscape of the financial market.
Samuel Kerr, global head of equity capital markets at Mergermarket, noted, “What is now clear is we are in a very different IPO market to the one we envisaged just a few weeks ago.”
Initially, Oura planned to price its shares between $40 and $44 on the Nasdaq stock market index, which would have granted it an implied market valuation of $15 billion.
In the financial year ending September 30, 2025, Oura reported a pre-tax profit of $23.5 million on sales totaling $907.8 million, significantly improving from the previous year’s pre-tax profit of $6.2 million.
According to the company’s most recent quarterly figures, Oura’s pre-tax income for the nine months ending June 30 this year stood at $70 million on $1.2 billion in sales. Founded in 2013 in Finland, Oura’s global headquarters are located in San Francisco. The company produces smart rings, priced at over $300, capable of tracking various health metrics like heart rate and sleep patterns through a dedicated application.
Currently, Oura faces a class action lawsuit from the Clarkson Law Firm, which accuses the company of false advertising regarding the accuracy of sleep tracking claims made by its rings. The lawsuit posits that “Oura rings cannot measure one’s sleep or cycles. That’s because sleep happens in the brain, not on one’s finger.”
It has been reported that Oura’s decision to postpone its IPO is unrelated to the ongoing lawsuit. An Oura spokesperson reiterated the company’s confidence in their scientific claims, stating, “We stand behind our science, research and accuracy claims,” and describing how the Oura Ring estimates sleep stages using a combination of physiological signals.
Editor’s Take
The postponement of Oura’s IPO underscores the fluctuating dynamics of the tech market amidst economic uncertainties. For investors, this signifies a cautious approach, while for consumers, the continued innovation in health monitoring remains a priority. Businesses may need to recalibrate expectations as they navigate similar challenges, highlighting the evolving landscape of IPO opportunities.
Source: www.bbc.co.uk
